Is the efficacy of psoralen plus ultraviolet A therapy for vitiligo enhanced by concurrent topical calcipotriol? A placebo-controlled double-blind study


Ermis O., Alpsoy E., Cetin L., Yilmaz E.

BRITISH JOURNAL OF DERMATOLOGY, vol.145, no.3, pp.472-475, 2001 (SCI-Expanded) identifier identifier identifier

  • Publication Type: Article / Article
  • Volume: 145 Issue: 3
  • Publication Date: 2001
  • Doi Number: 10.1046/j.1365-2133.2001.04286.x
  • Journal Name: BRITISH JOURNAL OF DERMATOLOGY
  • Journal Indexes: Science Citation Index Expanded (SCI-EXPANDED), Scopus
  • Page Numbers: pp.472-475
  • Keywords: calcipotriol, psoralen plus ultraviolet A therapy, randomized controlled trial, vitiligo, CALCIUM, COMBINATION
  • Akdeniz University Affiliated: Yes

Abstract

Background Encouraging results of previous uncontrolled trials suggest that calcipotriol may potentiate the efficacy of psoralen plus ultraviolet (UV) A (PUVA) therapy in patients with vitiligo.